tiprankstipranks
Trending News
More News >
Evoke Pharma (EVOK)
NASDAQ:EVOK
US Market
Advertisement

Evoke Pharma (EVOK) Technical Analysis

Compare
488 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Evoke Pharma’s (EVOK) Moving Averages Convergence Divergence (MACD) indicator is 0.37, suggesting Evoke Pharma is a Sell.
Evoke Pharma’s (EVOK) 20-Day exponential moving average is 4.81, while Evoke Pharma’s (EVOK) share price is $4.99, making it a Buy.
Evoke Pharma’s (EVOK) 50-Day exponential moving average is 4.23, while Evoke Pharma’s (EVOK) share price is $4.99, making it a Buy.

Evoke Pharma (EVOK) Pivot Points

Aug 14, 2025, 02:59 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.05
5.20
5.34
5.49
5.63
5.78
5.92
Fibonacci
5.20
5.31
5.38
5.49
5.60
5.67
5.78
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Evoke Pharma (EVOK) Moving Averages

Aug 14, 2025, 02:59 AM
Period
Simple
Exponential
MA5
5.39Sell
5.23Sell
MA10
4.99Sell
5.09Sell
MA20
4.74Buy
4.81Buy
MA50
3.94Buy
4.23Buy
MA100
3.39Buy
3.94Buy
MA200
4.03Buy
4.17Buy
Evoke Pharma’s (EVOK) 10-Day exponential moving average is 5.09, while Evoke Pharma’s (EVOK) share price is $4.99, making it a Sell.
Evoke Pharma’s (EVOK) 100-Day exponential moving average is 3.94, while Evoke Pharma’s (EVOK) share price is $4.99, making it a Buy.
Evoke Pharma’s (EVOK) stock price is $4.99 and Evoke Pharma’s (EVOK) 50-day simple moving average is 3.94, creating a Buy signal.
Evoke Pharma’s (EVOK) stock price is $4.99 and Evoke Pharma’s (EVOK) 100-day simple moving average is 3.39, creating a Buy signal.
Evoke Pharma’s (EVOK) stock price is $4.99 and Evoke Pharma’s (EVOK) 200-day simple moving average is 4.03, creating a Buy signal.

Evoke Pharma (EVOK) Technical Indicators

Aug 14, 2025, 02:59 AM
Name
Value
Implied Action
RSI (14)
54.43
Neutral
STOCH (9,6)
78.57
Neutral
STOCHRSI (14)
78.57
Neutral
MACD (12,26)
0.37
Sell
ADX (14)
34.62
Neutral
Williams %R
-34.45
Buy
CCI (14)
51.21
Neutral
ATR (14)
0.56
-
Ultimate Oscillator
48.16
Neutral
ROC
10.40
Buy
Evoke Pharma’s (EVOK) Relative Strength Index (RSI) is 54.43, creating a Neutral signal.
Evoke Pharma’s (EVOK) Trend Strength Indicator (ADX) is 34.62, creating a Neutral signal.
Evoke Pharma’s (EVOK) Commodity Channel Index (CCI) is 51.21, creating a Neutral signal.
Evoke Pharma’s (EVOK) Price Rate of Change (ROC) is 10.40, creating a Buy signal.

FAQ

Is EVOK a Buy, Hold, or Sell?
Based on EVOK’s technical indicators, EVOK is a Buy.
    What is EVOK’s RSI (14)?
    EVOK’s RSI (14) is 54.43, which suggests EVOK is a Neutral.
      What is EVOK’s MACD?
      EVOK’s MACD is 0.37, which suggests EVOK is a Sell.
        What is EVOK’s 5-day moving average?
        EVOK’s 5-day moving average is 5.39, which suggests EVOK is a Sell.
          What is EVOK’s 20-day moving average?
          EVOK 20-day moving average is 4.74, which suggests EVOK is a Buy.
            What is EVOK’s 50-day moving average?
            EVOK’s 50-day moving average is 3.94, which suggests EVOK is a Buy.
              What is EVOK’s 200-day moving average?
              EVOK’s 200-day moving average is 4.03, which suggests EVOK is a Buy.
                What is EVOK’s Williams % R (14)?
                EVOK’s Williams % R (14) is -34.45, which suggests EVOK is a Buy.
                  What is EVOK’s CCI (14)?
                  EVOK’s CCI (14) is 51.21, which suggests EVOK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis